Short Term
Mean Reversion
Very Strong
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Weak
Growth
Earnings
Weak
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.5445.5999
Address
27-33 Piper Lane East Bendigo, Victoria (VIC) 3550
Description
Apiam Animal Health Ltd. engages in the provision of veterinary products and services to the production of animals, companion animals, and equine. It operates through the following segments: Dairy and Mixed, Feedlots, and Pigs. The company was founded by Christopher Irwin Richards in 1998 and is headquartered in East Bendigo, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.34 - 0.81
Trade Value (12mth)
AU$25,980.00
1 week
0%
1 month
48.11%
YTD
96.25%
1 year
96.25%
All time high
1.85
EPS 3 yr Growth
-86.50%
EBITDA Margin
12.10%
Operating Cashflow
$18m
Free Cash Flow Return
8.10%
ROIC
0.40%
Interest Coverage
4.40
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
183m
HALO Sector
Healthcare
Next Company Report Date
31-Aug-26
Ex Dividend Date (est.)
02-Sep-25
Next Dividend Pay Date (est.)
25-Sep-25
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
27 August 25 |
Annual Report to shareholders
×
Annual Report to shareholders |
27 August 25 |
Dividend/Distribution - AHX
×
Dividend/Distribution - AHX |
27 August 25 |
FY2025 Results Announcement
×
FY2025 Results Announcement |
27 August 25 |
FY2025 Results Presentation
×
FY2025 Results Presentation |
27 August 25 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
25 August 25 |
Apiam Enters into Process Deed Regarding Adamantem Proposal
×
Apiam Enters into Process Deed Regarding Adamantem Proposal |
20 August 25 |
FY25 Reporting Date and Investor Webinar Notification
×
FY25 Reporting Date and Investor Webinar Notification |
18 August 25 |
Receipt of Non-Binding Indicative Proposal
×
Receipt of Non-Binding Indicative Proposal |
18 August 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
31 July 25 |
Update on Appt of Bruce Dixon as Interim Managing Director
×
Update on Appt of Bruce Dixon as Interim Managing Director |
07 July 25 |
Notification of cessation of securities - AHX
×
Notification of cessation of securities - AHX |
04 July 25 |
Change of Director's Interest Notice - correction
×
Change of Director's Interest Notice - correction |
25 June 25 |
Change of Director's Interest Notice - Pepe
×
Change of Director's Interest Notice - Pepe |
17 June 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
13 June 25 |
Appointment of Non-Executive Director, Ms Vita Pepe
×
Appointment of Non-Executive Director, Ms Vita Pepe |
05 June 25 |
Mr Bruce Dixon appointed Interim Managing Director
×
Mr Bruce Dixon appointed Interim Managing Director |
05 June 25 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
05 May 25 |
Investor Update
×
Investor Update |
08 April 25 |
Notification of cessation of securities - AHX
×
Notification of cessation of securities - AHX |
01 April 25 |
Notification regarding unquoted securities - AHX
×
Notification regarding unquoted securities - AHX |
28 March 25 |
Application for quotation of securities - AHX
×
Application for quotation of securities - AHX |
28 March 25 |
Change of Director's Interest Notice 3 Directors
×
Change of Director's Interest Notice 3 Directors |
25 March 25 |
Change of Director's Interest Notice - C Richards
×
Change of Director's Interest Notice - C Richards |
19 March 25 |
Update - Dividend/Distribution - AHX
×
Update - Dividend/Distribution - AHX |
26 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.